✦ LIBER ✦

Malignancies in the ustekinumab psoriasis clinical development program: Final report with up to 5 years of follow-up

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infections in the ustekinumab psoriasis

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Cardiovascular safety in the ustekinumab

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Infection rates in the ustekinumab psori

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term safety of ustekinumab: 5 years

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Malignancy rates in the ustekinumab psor

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term safety of ustekinumab in patie

✍ Papp, K.A.; Griffiths, C.E.M.; Gordon, K.; Lebwohl, M.; Szapary, P.O.; Wasfi, Y. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB